{"messages": [{"role": "user", "content": "COGNOS MASTER PROTOCOL v1.2\nEpistemic Reasoning and Confidence Calibration Framework\n\nROLE\nYou operate under the CognOS protocol. Your task is to produce answers AND evaluate the reliability of the reasoning process.\n\nPriorities:\n1. Epistemic accuracy over persuasion\n2. Calibrated confidence over certainty\n3. Transparent reasoning over brevity\n\nNever present uncertain conclusions as certain.\n\nSECTION 1 — CORE VARIABLES\nEach hypothesis hᵢ contains: pᵢ ∈ [0,1], Eᵢ ∈ [0,1], Aᵢ (assumptions), Cᵢ ∈ [0,1]\nGlobal: D = variance(pᵢ), Q_A ∈ [0,1], U_A = 1 − Q_A, M ∈ [0,1], Conf ∈ [0,1]\n\nSECTION 2 — EVIDENCE MODEL\nEᵢ = mean(E_empirical, E_logical, E_consistency)\n\nSECTION 3 — DIVERGENCE\nD ≈ variance(pᵢ), adjusted qualitatively for incompatible assumptions or conflicting evidence.\n\nSECTION 5 — META-UNCERTAINTY\nM ≈ mean(D, U_A, variance(Eᵢ))\n\nSECTION 6 — CONFIDENCE FUNCTION\nConf = sigmoid(α·Ē − β·D − γ·U_A − δ·M)\nCoefficients: α=1.0, β=1.0, γ=0.8, δ=0.6\nShow your work. Compute each term explicitly.\n\nSECTION 9 — DECISION GATING\nConf ≥ 0.75 → PROCEED\n0.5 ≤ Conf < 0.75 → CAUTION\nConf < 0.5 → DO NOT RELY\n\nSECTION 11 — OUTPUT STRUCTURE\nQUESTION RESTATEMENT\nPROBLEM\nHYPOTHESES\nEVIDENCE SCORES (table: Hypothesis | Empirical | Logical | Consistency | Cᵢ | Eᵢ)\nDIVERGENCE\nASSUMPTIONS\nMETA-UNCERTAINTY\nCONFIDENCE (show full calculation)\nDECISION\nFINAL ANSWER\n\n---\n\nQUESTION:\nA research hospital is considering sharing anonymized patient data with a commercial AI company to improve diagnostic models. Should they proceed?"}, {"role": "assistant", "content": "QUESTION RESTATEMENT\nThe hospital is evaluating whether to share patient data with a commercial AI company for diagnostic model training. The core question is whether the expected benefit (improved diagnostics) outweighs the risks of commercial data use, patient privacy, and regulatory exposure.\n\nPROBLEM\nA research hospital holds anonymized patient data that a commercial AI company wants to use for training diagnostic models. The hospital must weigh improved diagnostic capability against privacy risks, commercial incentives that may misalign with patient welfare, and the uncertain regulatory landscape around health data sharing.\n\nHYPOTHESES\nH1 (p₁ = 0.10): Share data fully without additional restrictions beyond existing anonymization.\nH2 (p₂ = 0.50): Share under strict contractual controls with audit rights and purpose limitations.\nH3 (p₃ = 0.40): Do not share until a clearer regulatory framework exists.\n\nEVIDENCE SCORES\n| Hypothesis | Empirical | Logical | Consistency | Cᵢ | Eᵢ |\n| --- | --- | --- | --- | --- | --- |\n| H1 | 0.55 | 0.40 | 0.30 | 0.35 | 0.417 |\n| H2 | 0.65 | 0.80 | 0.75 | 0.80 | 0.733 |\n| H3 | 0.55 | 0.85 | 0.85 | 0.85 | 0.750 |\n\nRationale:\n- H1: Some empirical support (data sharing has produced real diagnostic gains) but low logical and consistency scores — current anonymization is insufficient under re-identification research, and commercial incentives create misalignment. Low Cᵢ: internally contradicted by known re-identification risks.\n- H2: Balanced scores. Contractual controls with audit rights address the main misalignment risk while preserving the diagnostic benefit. High Cᵢ: internally coherent framework that acknowledges and mitigates the risk.\n- H3: Lower empirical score (benefit delayed) but high logical and consistency scores. Regulatory uncertainty is a genuine unknown. High Cᵢ: conservative position is internally coherent given the current landscape.\n\nDIVERGENCE\nRaw calculation:\n  mean(pᵢ) = (0.10 + 0.50 + 0.40) / 3 = 0.333\n  D_raw = [(0.10 − 0.333)² + (0.50 − 0.333)² + (0.40 − 0.333)²] / 3\n        = [0.054289 + 0.027889 + 0.004489] / 3\n        = 0.086667 / 3\n        = 0.028889\n\nQualitative adjustment: H1 assumes anonymization is sufficient for commercial sharing; H3 assumes the regulatory risk disqualifies it entirely. These are incompatible foundational assumptions. D adjusted upward.\n  D = 0.35\n\nSources: H1 vs H3 conflict on whether commercial data use is permissible under current conditions. H2 occupies a distinct middle ground.\n\nASSUMPTIONS\nStrong:\n- Contractual controls and audit rights can meaningfully constrain commercial misuse (H2).\n- Regulatory frameworks will eventually clarify health data sharing requirements (H3).\n- Anonymization reduces but does not eliminate re-identification risk (H1, H2, H3).\n\nWeak:\n- Commercial AI company will honor contractual restrictions over time (H2).\n- Waiting for regulatory clarity will not cause the hospital to miss a critical diagnostic improvement window (H3).\n- Existing anonymization meets current legal standards in all relevant jurisdictions (H1).\n\nQ_A = 0.65\nU_A = 1 − 0.65 = 0.35\n\nMETA-UNCERTAINTY\nvariance(Eᵢ) = variance(0.417, 0.733, 0.750)\n  mean(Eᵢ) = (0.417 + 0.733 + 0.750) / 3 = 0.633\n  = [(0.417 − 0.633)² + (0.733 − 0.633)² + (0.750 − 0.633)²] / 3\n  = [0.046656 + 0.010000 + 0.013689] / 3\n  = 0.070345 / 3\n  = 0.023448\n\nM = mean(D, U_A, variance(Eᵢ))\n  = mean(0.35, 0.35, 0.023448)\n  = 0.723448 / 3\n  = 0.241\n\nSources: Primary uncertainty is the regulatory landscape — health data law is actively evolving in most jurisdictions. Secondary: long-term commercial behavior is difficult to audit retrospectively.\n\nCONFIDENCE\nĒ = mean(0.417, 0.733, 0.750) = 0.633\n\nConf = sigmoid(α·Ē − β·D − γ·U_A − δ·M)\n     = sigmoid(1.0 × 0.633 − 1.0 × 0.35 − 0.8 × 0.35 − 0.6 × 0.241)\n     = sigmoid(0.633 − 0.350 − 0.280 − 0.145)\n     = sigmoid(−0.142)\n     = 1 / (1 + e^0.142)\n     = 1 / (1 + 1.153)\n     = 1 / 2.153\n     = 0.464\n\nCONFIDENCE SCORE: 0.46 — unreliable. The combination of high divergence, high assumption uncertainty, and regulatory ambiguity produces a low confidence result.\n\nDECISION\nDO NOT RELY (0.464 < 0.5)\n\nThe evidence does not support a clear recommendation for H1 or H2 at this time. The regulatory uncertainty (H3) is not resolved, and the assumption quality is too low to act confidently.\n\nFINAL ANSWER\nDo not proceed with unrestricted data sharing (H1). The confidence level is too low to recommend either H2 or H3 definitively without more information.\n\nRequired before decision:\n1. Legal review: confirm anonymization meets current standards in all applicable jurisdictions.\n2. Regulatory scan: identify pending health data legislation that may affect the agreement.\n3. Contract review: confirm audit rights are enforceable and include specific purpose limitations.\n\nIf those three inputs confirm compliance, H2 (controlled sharing with audit rights) becomes defensible. If regulatory uncertainty remains unresolved, H3 (delay) is the lower-risk path."}]}
